Your Patient Has Already Been Through A Dozen Of You

They did not come into your exam room hopeful. They came in guarded. They brought a list because the last time they did not bring a list something important got missed. They chose their words carefully because they have learned that certain words make doctors stop listening. They watched your face when they described their symptoms to see if you were going to be the one who believed them or the one who was going to add another normal to a chart full of normals while they got sicker.

They are not difficult. They are not anxious. They are not drug seeking. They are not making it up.

They are exhausted. And they are sitting across from you because they have not given up yet.

This page is written from the other side of that exam table. Not as an accusation. Not as a demand. As an honest account of what the diagnostic loop looks like from inside it and what the doctors who finally made a difference actually did differently.

What The Diagnostic Loop Actually Costs

The average celiac diagnosis takes six to ten years from first symptoms. Hereditary fructose intolerance goes undiagnosed for decades in most cases. ME/CFS patients see an average of seven doctors before anyone takes them seriously. These are not edge cases. These are documented averages across large patient populations.

During those years the patient is not just suffering physically. They are absorbing a cumulative message from the medical system that their experience is not real, not serious, or not worth the time required to investigate properly. They are being sent home with diagnoses of anxiety, depression, IBS, hypochondria, and functional disorder — not because those diagnoses are accurate but because they are available and the appointment is twelve minutes long.

The psychological damage of that accumulation is real and it follows the patient into every subsequent appointment including yours. The defensiveness you may encounter is not a personality trait. It is scar tissue from a system that failed them repeatedly.

Understanding that does not mean accepting abuse. It means understanding the context you are walking into and adjusting your approach accordingly.

The Conditions Most Likely To Be In Your Exam Room Undiagnosed

Celiac Disease

Celiac disease affects approximately one percent of the global population. Diagnosis rates suggest that for every person diagnosed there are several more undiagnosed. The classic presentation — diarrhea, weight loss, obvious malabsorption — represents a minority of cases. The majority present atypically.

Atypical presentations include chronic fatigue, neurological symptoms, skin conditions including dermatitis herpetiformis frequently misdiagnosed as HSV-2, joint pain, migraines, mood disorders, anemia unresponsive to supplementation, osteoporosis in younger patients, and reproductive issues. A patient presenting with any combination of systemic symptoms that do not resolve and do not fit a clean diagnostic picture deserves celiac screening.

The critical distinction for your exam room is this: celiac disease is not the same as gluten sensitivity and it is not a wheat allergy. Celiac disease is an autoimmune condition driven by the HLA-DQ2 and HLA-DQ8 genetic markers. In some but not all cases it produces measurable antibodies and causes documented damage to the lining of the small intestine. However, the current standard tests — IgA antibody bloodwork and intestinal biopsy — have proven in my research to be 30% or less accurate. That means a negative result does not reliably rule out celiac disease. Many patients with the condition still receive false-negative results. The stakes of missing it are serious: progressive bone loss, a significantly elevated risk of certain cancers, and the potential triggering of additional autoimmune diseases if left untreated.

DNA Screening is a blood draw OR cheek swab. It costs almost nothing relative to the years of downstream treatment for conditions that would resolve with a correct diagnosis.

Hereditary Fructose Intolerance

HFI is caused by aldolase B enzyme deficiency and results in the inability to safely metabolize fructose. It is not fructose malabsorption. The distinction matters clinically.

HFI patients frequently present with a triad of findings that appear unrelated until the upstream cause is identified — elevated triglycerides, NAFLD or hepatic steatosis, and reactive hypoglycemia. Any one of those findings alone gets treated as its own condition. The triad together should prompt consideration of HFI as a possible upstream cause.

A critical safety note for your exam room. There is no simple safe direct clinical test for aldolase B deficiency. The fructose loading or challenge test is dangerous and has caused documented deaths in patients with undiagnosed HFI. Do not order it. Molecular genetic testing of the ALDOB gene misses over ten percent of HFI alleles worldwide and over thirty three percent in some American populations. A negative genetic test does not rule out HFI. Clinical diagnosis is based on life history, family history, symptom pattern, and response to dietary elimination.

If a patient tells you they believe they may have hereditary fructose intolerance and specifically requests that no fructose challenge test be administered — take that seriously. They may have done their homework more thoroughly than the referral chain that preceded them.

ME/CFS

Myalgic encephalomyelitis and chronic fatigue syndrome is a complex neuroimmune condition affecting an estimated seventeen to twenty four million Americans. It is not depression. It is not deconditioning. It is not a functional disorder that responds to cognitive behavioral therapy or graded exercise.

The 2015 Institute of Medicine report — now the National Academy of Medicine — established diagnostic criteria and explicitly stated that ME/CFS is a serious, chronic, complex systemic disease that often causes profound disability. Graded exercise therapy is contraindicated. Post-exertional malaise is the hallmark feature and it is pathological, not behavioral.

EBV has been identified as a significant upstream trigger. A 2022 Harvard military study of ten million personnel found a thirty two fold increase in MS risk after EBV infection. A 2018 Nature Genetics study found that EBV protein EBNA2 binds to genome locations associated with seven autoimmune diseases including celiac, lupus, MS, and rheumatoid arthritis. The viral foundation of ME/CFS and related conditions is not fringe science. It is peer reviewed and published in the highest tier journals.

A patient presenting with profound fatigue, post-exertional malaise, cognitive dysfunction, and orthostatic intolerance who has not responded to standard interventions deserves an ME/CFS evaluation using current diagnostic criteria. Not a depression screening and a referral to psychiatry.

The Lab Values That Get Missed

Normal is a range. Normal for a population is not necessarily normal for a specific patient. And some findings that fall within the normal range are clinically significant when viewed in context.

Vitamin D at the low end of normal in a patient with suspected celiac deserves attention. A gut too damaged to absorb nutrients will produce low vitamin D even with supplementation. Treating the number without investigating why it is low misses the diagnosis.

Elevated triglycerides treated with statins without investigating upstream cause misses HFI, NAFLD, and metabolic syndrome as potential drivers. Statins do not treat triglycerides. Fenofibrate is indicated for elevated triglycerides. If a patient fought for fenofibrate and got better results than they did on statins — that is clinically significant information.

Persistently elevated white blood cell count in a patient with systemic symptoms and no identified infectious source deserves ongoing investigation. Dismissing it as a lab variation across multiple draws over multiple years is not adequate.

Hepatic steatosis found incidentally on imaging ordered for another purpose is not a throwaway finding. It belongs in the differential. In the context of elevated triglycerides and reactive hypoglycemia it points toward HFI as a possible upstream cause worth investigating.

The Mechanic's Differential

A good mechanic does not replace parts until they have run the diagnostic. They follow the evidence. They consider what fits and what does not. They do not assume the obvious answer is correct without ruling out the less obvious ones.

The patients who end up in chronic diagnostic loops are frequently patients whose presentation does not fit the most common expression of a condition. The celiac patient without classic GI symptoms. The HFI patient whose triglycerides and NAFLD were treated as separate findings for a decade. The ME/CFS patient whose profound fatigue was attributed to depression because depression was available and ME/CFS required more investigation.

Running the full differential costs more time in the short term. It costs dramatically less in the long term — in repeat appointments, in downstream conditions, in the accumulated damage of years of incorrect treatment, and in the patient who eventually figures it out themselves through research and arrives in your exam room already knowing the answer and just needing someone to confirm it.

Be the doctor who ran the differential.

The Genetic Architecture Worth Understanding

HLA-DQ2 and HLA-DQ8 are genetic markers for celiac disease. HLA-DQ2 in particular — present in approximately thirty percent of the general population — is associated with elevated risk for multiple autoimmune conditions beyond celiac. The 2025 Frontiers in Immunology paper on ancestral HLA-II haplotypes documents how these immune variants were selected under infectious pressure and produce immune hyperreactivity in the modern environment.

A patient with HLA-DQ2 who presents with multiple autoimmune conditions stacking over time is not unlucky. They are expressing a documented genetic predisposition with a mechanistic explanation in the peer reviewed literature. Understanding that architecture changes the clinical picture from a complicated patient to a patient with a coherent underlying pattern.

EBV establishes permanent latency in B cells after primary infection. In genetically predisposed individuals — particularly those carrying HLA-DQ2 or HLA-DRB1 — reactivation events triggered by subsequent infections, immune stressors, or vaccination in rare cases can initiate or accelerate autoimmune cascades. This is not fringe immunology. It is documented in Nature Genetics, Science, and Frontiers in Immunology.

What The Patients Who Got Better Had In Common

They had a doctor who listened past the first appointment.

They had a doctor who looked at the full picture instead of treating each finding in isolation.

They had a doctor who said I do not know but let us find out instead of normal see you in six months.

They had a doctor who took their research seriously instead of dismissing it as internet medicine.

They had a doctor who ran the test they asked for even when the odds seemed low because the cost of the test was low and the cost of being wrong was high.

They had a doctor who understood that a patient who has done years of research into their own condition is not a difficult patient. They are a resource. They have data points no chart captures. They have pattern recognition built from living inside this body for decades. That information is clinically useful if you are willing to receive it.

The Protective Questions Your Patient May Ask

If a patient says any of the following to you — take it seriously.

"I believe I may have hereditary fructose intolerance, not fructose malabsorption. I am requesting that no fructose challenge test be administered until HFI has been properly considered."

"I need to know the inactive ingredients in this medication before I take it."

"I need the substrate used in this breath test before I drink anything."

"I want to be tested for celiac before I go gluten free because I understand the diet affects the test results."

"I want terminal ileum intubation confirmed during my colonoscopy."

These are not the questions of an anxious patient who has been down too many internet rabbit holes. These are the questions of a patient who has done serious research, understands the stakes, and is trying to protect themselves from documented clinical errors that have harmed people with these conditions.

Answer them directly. Take them seriously. They are good questions.

The Doctor Who Made The Difference

In a diagnostic loop that involved twenty eight doctors, hundreds of blood draws, MRIs, CT scans, and X-rays over several years — the answer was ultimately found not in a specialist's office but through the patient's own research.

That is not an indictment of every doctor in that loop. Most of them were doing their jobs within the constraints of a system that does not reward the kind of time and investigation that complex cases require.

But somewhere in that loop there could have been a doctor who looked at the full picture. Who noticed that the elevated triglycerides and the NAFLD and the reactive hypoglycemia were not three separate problems but one upstream problem with three downstream expressions. Who ran the celiac panel on a patient presenting with systemic symptoms that did not fit a clean diagnosis. Who took seriously the family history and the lifelong symptom pattern and the fact that this patient had been sick since childhood.

That doctor would have changed everything. Years earlier. With less damage accumulated.

You could be that doctor for someone sitting in your waiting room right now.

That is the only ask this page makes.

I am not a doctor. I am not a medical educator. I am a patient who spent years in the diagnostic loop and eventually figured it out himself. Everything on this page is personal testimony supported by peer reviewed literature cited throughout this site. Links to primary sources are available in the medical library. Please consult current clinical guidelines and peer reviewed literature for diagnostic and treatment decisions.